SURx-TV
This article was originally published in The Gray Sheet
Executive Summary
Radio frequency bladder neck suspension system gains FDA market clearance for use during a transvaginal approach, easing surgical access and making the procedure less invasive, SURx says. The procedure was cleared for laparoscopic use in January (1"The Gray Sheet" Feb. 18, 2002, p. 17)...
You may also be interested in...
SURx-LP Minimally Invasive RF System For Incontinence To Ship In March
SURx, Inc. anticipates filing a 510(k) for its Solarant non-surgical, radiofrequency (RF) bladder neck suspension device for stress urinary incontinence (SUI) in 2003
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.